# Venlafaxine for Hot Flashes After Breast Cancer

> **NCT00198250** · PHASE2 · COMPLETED · sponsor: **Indiana University** · enrollment: 75 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** venlafaxine

## Key facts

- **NCT ID:** NCT00198250
- **Lead sponsor:** Indiana University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-05
- **Primary completion:** 2005-11
- **Final completion:** 2005-11
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2008-11-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00198250

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00198250, "Venlafaxine for Hot Flashes After Breast Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00198250. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*